IDEXX Laboratories Inc (IDXX)

NASDAQHealthcare

$626.2
-$2.77 (-0.4%)
Market closed

February 17, 2026 at 21:00 UTC

Interactive Chart
IDXX
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

07:47:29 UTC

About IDEXX Laboratories Inc

Name

IDEXX Laboratories Inc

CEO

Jonathan J. Mazelsky

Industry

Healthcare

Year Founded

1983

Employees

11,000

IDEXX Laboratories Inc is a veterinary diagnostics and software company that helps animal health providers turn samples and records into practical decisions. Clinics rely on in-clinic instruments, reference lab services, and connected practice tools that present results in clear context rather than scattered reports. The operating idea is straightforward: make testing easy to run, make data easy to read, and keep workflows familiar so teams can move from intake to treatment without losing time. In water quality and livestock testing, the same discipline applies — methods that are auditable and results that travel well between sites. Regional units adapt to local regulation while holding to shared quality systems and data safeguards. Within the healthcare ecosystem, IDEXX occupies the quiet infrastructure of veterinary care, supporting better medicine through repeatable processes that work on busy days as well as calm ones.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 13 Buy, 7 Hold, 1 Sell
Buy13
Hold7
Sell1
Fundamentals & Financials
Revenue (TTM)
$4.3B
Net Income (TTM)
$1B
EPS (TTM)
$13.17
ROA (TTM)
31.62%
Current Ratio
1.23
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement
ItemQ4 2025
Revenue$1,090.5M
Cost of Sales$432,465K
Gross Profit$658,114K
Operating Income$315,605K
Net Income$248,188K
EPS$3.1
Technical Indicators

IDEXX Laboratories Inc's Technical Indicators Summary

IDXX is exhibiting a generally bullish technical profile as its price trades comfortably above key moving averages, including the 10-, 50-, and 200-day lines, signaling sustained upward momentum. The MACD and momentum indicators reinforce this positive trend, showing solid buying strength, while the RSI and CCI suggest a balanced momentum without being overextended. Although the ADX indicates a modest trend strength, volume trends, reflected in a rising OBV, support the price appreciation. Volatility remains moderate with the ATR showing steady price movement within the Bollinger Bands. Overall, the technical signals highlight a controlled but confident uptrend for IDXX at this time.

Buy
13 signals
Neutral
7 signals
Sell
1 signal
Overall: Bullish62% Bullish signals
IndicatorValue
RSI (14)
56.68
Stochastic %K (14, 3, 3)
78.68
CCI (20)
92.09
WPR (14)
-17.11
Momentum (10)
45.38
MFI
56.34
MACD Level (12, 26)
4.31
Bollinger Bands
$667.61 - $730.53
ATR (14)
$15.72 (2.20%)
ADX (14)
14.77
OBV
11,579,300
Simple Moving Averages
$597.19 - $710.61(5 indicators)
Exponential Moving Averages
$599.45 - $709.29(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the bell, IDXX was still trading below yesterday, reflecting a -0.505% opening gap down and a close near 626.17. Into the bell, a flat sector move (-0.16%) kept the backdrop muted. IDXX's decline appears to reflect a broadly muted sector move amid limited recent headlines affecting the company.

Price Change

from $629.35 close

-$3.18

Trading Volume

Below avg (612.0K)

440.3K

vs S&P 500 Today

Strong Underperformance

-3.33%

52-Week Position

Upper range

65.2%

Updated: February 17, 2026 at 21:16 UTC

Quote Summary
OpenPrevious Close
$628.36$629.35
Day Range52 Week Range
$623.28 - $632.7$356.14 - $769.98
VolumeAvg. Volume
440.3K550.8K
Market CapP/E Ratio
$50B47.8